YU165775A - Process for preparing new derivatives of 3-amino-2-hydroxy-1-phenoxy-propane - Google Patents

Process for preparing new derivatives of 3-amino-2-hydroxy-1-phenoxy-propane

Info

Publication number
YU165775A
YU165775A YU01657/75A YU165775A YU165775A YU 165775 A YU165775 A YU 165775A YU 01657/75 A YU01657/75 A YU 01657/75A YU 165775 A YU165775 A YU 165775A YU 165775 A YU165775 A YU 165775A
Authority
YU
Yugoslavia
Prior art keywords
phenoxy
propane
hydroxy
amino
new derivatives
Prior art date
Application number
YU01657/75A
Other languages
English (en)
Inventor
H Demarne
Original Assignee
Cm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm Ind filed Critical Cm Ind
Publication of YU165775A publication Critical patent/YU165775A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU01657/75A 1974-06-28 1975-06-27 Process for preparing new derivatives of 3-amino-2-hydroxy-1-phenoxy-propane YU165775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28925/74A GB1501632A (en) 1974-06-28 1974-06-28 Aromatic ketones having cardiovascular activity

Publications (1)

Publication Number Publication Date
YU165775A true YU165775A (en) 1982-02-28

Family

ID=10283421

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01657/75A YU165775A (en) 1974-06-28 1975-06-27 Process for preparing new derivatives of 3-amino-2-hydroxy-1-phenoxy-propane

Country Status (17)

Country Link
US (2) US4252825A (cs)
JP (2) JPS5826743B2 (cs)
AR (1) AR205388A1 (cs)
AT (1) AT343098B (cs)
BE (1) BE830766A (cs)
CA (1) CA1052820A (cs)
CS (1) CS197248B2 (cs)
DE (1) DE2528147A1 (cs)
DK (1) DK143555C (cs)
ES (1) ES438931A1 (cs)
FR (1) FR2276032A1 (cs)
GB (1) GB1501632A (cs)
IE (1) IE41386B1 (cs)
NL (1) NL7507703A (cs)
SE (2) SE416546B (cs)
YU (1) YU165775A (cs)
ZA (1) ZA754141B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
JPH0516363Y2 (cs) * 1986-08-01 1993-04-28
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
AU2004242777B2 (en) * 2003-05-30 2011-05-12 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CA2627599A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
ES3007652T3 (en) 2019-01-18 2025-03-20 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (cs) * 1962-12-11
DE1493454C3 (de) * 1963-08-26 1980-04-30 C.H. Boehringer Sohn, 6507 Ingelheim 1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
GB1231783A (en) * 1967-05-16 1971-05-12 May & Baker Ltd Benzene derivatives
JPS512115B2 (cs) * 1971-09-28 1976-01-23
JPS4911847A (cs) * 1972-05-20 1974-02-01
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity

Also Published As

Publication number Publication date
IE41386B1 (en) 1979-12-19
AT343098B (de) 1978-05-10
ZA754141B (en) 1976-06-30
DE2528147A1 (de) 1976-01-15
ATA497275A (de) 1977-09-15
IE41386L (en) 1975-12-28
DK292475A (da) 1975-12-29
SE416546B (sv) 1981-01-19
CA1052820A (en) 1979-04-17
JPS5826743B2 (ja) 1983-06-04
US4302601A (en) 1981-11-24
DK143555C (da) 1982-02-01
AU8256675A (en) 1977-01-06
GB1501632A (en) 1978-02-22
FR2276032A1 (fr) 1976-01-23
ES438931A1 (es) 1977-05-16
SE7507359L (sv) 1975-12-29
JPS5123233A (en) 1976-02-24
JPS5929574B2 (ja) 1984-07-21
US4252825A (en) 1981-02-24
BE830766A (fr) 1975-12-29
CS197248B2 (en) 1980-04-30
DK143555B (da) 1981-09-07
SE417087B (sv) 1981-02-23
SE7812646L (sv) 1978-12-08
JPS58140050A (ja) 1983-08-19
FR2276032B1 (cs) 1979-08-10
AR205388A1 (es) 1976-04-30
NL7507703A (nl) 1975-12-30

Similar Documents

Publication Publication Date Title
EG12063A (en) Process for preparing of 16-oxygenated phosphanoic acid derivatives
YU37156B (en) Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU171684B (hu) Sposob poluchenija proizvodnykh 18-metil-19-nor-20-okso-pregnana
YU39113B (en) Process for preparing 2-arylamino-2-imidazoline derivatives
YU165775A (en) Process for preparing new derivatives of 3-amino-2-hydroxy-1-phenoxy-propane
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
HU171804B (hu) Sposob poluchenija proizvodnykh 7-metoksi-6-tiatetraciklina
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
CS185578B2 (en) Process for preparing derivatives of 13-thiaprostanic acid
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
ZA753180B (en) Process for preparation of abietamide derivatives
CS189642B2 (en) Process for preparing derivatives of cephalosporic acid
CS193514B2 (en) Process for preparing oligomere derivatives of aluminiumhydride
EG11715A (en) Process for preparing of tetracycline derivatives
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
HU171325B (hu) Sposob poluchenija 2-amino-2-imidazolina
CS187458B2 (en) Process for preparing new derivatives of phenothiazine
CS181798B2 (en) Process for preparing derivatives of prostanic acid
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
HU171206B (hu) Sposob poluchenija novykh proizvodnykh fenil-piridil-allilamina
YU157375A (en) Process for preparing new ergopetine derivatives
CS188961B2 (en) Process for preparing new derivatives of benzhydryloxy-alkylamine
CS188960B2 (en) Process for preparing new derivatives of 2-phenylindole
YU39338B (en) Process for preparing indolo-quinolizisdine derivatives